Cargando…

Defining the New Poor

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Scientific Press 1920
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5246876/ https://www.ncbi.nlm.nih.gov/pubmed/29829518

Ejemplares similares

On the Hunt: Searching for Poorly Defined Camouflaged Targets
por: Hess, Alyssa S., et al.
Publicado: (2016)

Defining the Conformational Features of Anchorless, Poorly Neuroinvasive Prions
por: Bett, Cyrus, et al.
Publicado: (2013)

What Number of Oocytes Is Appropriate for Defining Poor Ovarian Response?
por: Kim, Seul Ki, et al.
Publicado: (2015)

The Primacy of Public Health Considerations in Defining Poor Quality Medicines
por: Newton, Paul N., et al.
Publicado: (2011)

The juvenile fibromyalgia syndrome (JFMS): a poorly defined disorder
por: Vincenzo, de Sanctis, et al.
Publicado: (2019)

Defining the Cellular Basis for Poor Muscle Performance in Diabetic Peripheral Neuropathy
por: Bohnert, Kathryn L., et al.
Publicado: (2019)

Quantifying fish range shifts across poorly defined management boundaries
por: Palacios-Abrantes, Juliano, et al.
Publicado: (2023)

Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis
por: Overbeck, Tobias Raphael, et al.
Publicado: (2020)

Unique epigenetic gene profiles define human breast cancers with poor prognosis
por: Peña-Llopis, Samuel, et al.
Publicado: (2016)

Defining Energy-Dense, Nutrient-Poor Food and Drinks and Estimating the Amount of Discretionary Energy
por: Biltoft-Jensen, Anja, et al.
Publicado: (2022)

Defining Disease Heterogeneity to Guide the Empirical Treatment of Febrile Illness in Resource Poor Settings
por: White, Lisa J., et al.
Publicado: (2012)

Healthy control subjects are poorly defined in case-control studies of irritable bowel syndrome
por: Ghorbani, Shireen, et al.
Publicado: (2015)

Low PKCa expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome
por: Milani, Gloria, et al.
Publicado: (2014)

The New Poor
Publicado: (1920)

The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
por: Hepburn, A. C., et al.
Publicado: (2019)

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
por: Tekpli, Xavier, et al.
Publicado: (2019)

Copy number alteration signature defines undifferentiated pleomorphic sarcomas and leiomyosarcomas with poor prognosis
por: Silveira, Sara Martoreli, et al.
Publicado: (2013)

Sickness and the New Poor
Publicado: (1920)

Arthrofibrosis is a common but poorly defined complication in multiligament knee injuries: a systematic review
por: Fahlbusch, Hendrik, et al.
Publicado: (2022)

Defining microbiota for developing new probiotics
por: Collado, Maria Carmen, et al.
Publicado: (2012)

New Attempts to Define and Clarify Lupus
por: Alarcón-Riquelme, Marta E.
Publicado: (2019)

Defining the Role of Medication Adherence in Poor Glycemic Control among a General Adult Population with Diabetes
por: Feldman, Becca S., et al.
Publicado: (2014)

Coherence between Existing System of Defining Urban Poor with Kuppuswamy and Hashim's System; Which is More Relevant?
por: Patil, Sanjivani Vishwanath, et al.
Publicado: (2021)

Poor Neonatal Adaptation After Antidepressant Exposure During the Third Trimester in a Geographically Defined Cohort
por: Brumbaugh, Jane E., et al.
Publicado: (2023)

The New Poor-Law Orders
Publicado: (1914)

Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas
por: KATAGIRI, HIROSHI, et al.
Publicado: (2015)

Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
por: Hepburn, A. C., et al.
Publicado: (2019)

Classifications of good versus poor outcome following knee arthroplasty should not be defined using arbitrary criteria
por: Riddle, Daniel L., et al.
Publicado: (2020)

Defining characteristics and conservation of poorly annotated genes in Caenorhabditis elegans using WormCat 2.0
por: Higgins, Daniel P, et al.
Publicado: (2022)

Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
por: Keck, Bastian, et al.
Publicado: (2013)

A New Voice for the Poor
por: Hotez, Peter
Publicado: (2007)

Defining new SNARE functions: the i-SNARE
por: Di Sansebastiano, Gian-Pietro
Publicado: (2013)

Defining severe asthma – an approach to find new therapies
por: Nanzer, Alexandra M., et al.
Publicado: (2014)

New Treatment Paradigms Defined for Chronic Lymphocytic Leukemia
por: Moran, Mollie, et al.
Publicado: (2017)

Defining a Subgroup Treatable for Laparoscopic Surgery in Poorly Differentiated Early Gastric Cancer: the Role of Lymph Node Metastasis
por: Huo, Zhi-bin, et al.
Publicado: (2012)

High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Shi, Bentao, et al.
Publicado: (2015)

Expression of LAG-3 defines exhaustion of intratumoral PD-1(+) T cells and correlates with poor outcome in follicular lymphoma
por: Yang, Zhi-Zhang, et al.
Publicado: (2017)

Poor overall survival in hyperhaploid multiple myeloma is defined by double-hit bi-allelic inactivation of TP53
por: Ashby, Cody, et al.
Publicado: (2019)

Linguine technique for excision of lentigo maligna and poorly defined non-melanotic skin cancer – A case series
por: Ward, Joseph, et al.
Publicado: (2019)

A New Methodology for Defining Radon Priority Areas in Spain
por: Fernández, Alicia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8i642ms3m9b6bd9pc66523tnqo